Investing
The round included a strategic investment from pharma giant Gilead Sciences to expand their partnership for decentralized and hybrid trials.
The firm plans to expand its chronic disease treatments across more therapeutic areas.
Also: Imagene AI raises $21.5 million across two rounds for precision cancer care, and Capable Health scores $6 million in seed funding to help providers build healthcare apps.
The round comes nearly a year after the company announced it had raised $45 million in Series C financing.
It plans to develop an in-house cloud platform.
The startup's offerings include pelvic floor therapy, C-section recovery and lactation consulting.
Its fresh funds will support its product development and international expansion efforts.
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
The startup scooped up $14 million in Series A funding in January 2021.
It plans to expand its coverage in the domestic market.